How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like Launching This Week, A Look at Biogen's Spinoff January 29, 2017 Cellectis Reports Results From Annual General Meeting Held On June 26, 2017 June 26, 2017 MEDICREA Releases First Quarter Sales For 2017 April 13, 2017
